Refining Treatment Decisions in HCV-Infected Patients with Decompensated Cirrhosis: Frequency and Predictors of Recompensation with Direct-Acting Antiviral (DAA) Therapy

被引：0
|
作者：
Radhakrishnan, Kavita [1 ]
Dodge, Jennifer L. [2 ]
McKinney, Jeff [1 ]
Catalli, Lisa [1 ]
Straley, Stephanie [3 ]
Price, Jennifer C. [4 ]
Terrault, Norah [4 ]
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Surg, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Liver Transplant, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Med, San Francisco, CA 94143 USA
来源：
HEPATOLOGY | 2018年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1227
引用
收藏
页码：712A / 712A
页数：1
相关论文
共 50 条
  • [1] Real-world experience with direct-acting antiviral therapy in HCV-infected patients with cirrhosis and esophageal varices
    Brzdek, Michal
    Zarebska-Michaluk, Dorota
    Kukla, Michal
    Janocha-Litwin, Justyna
    Dybowska, Dorota
    Janczewska, Ewa
    Lorenc, Beata
    Berak, Hanna
    Mazur, Wlodzimierz
    Tudrujek-Zdunek, Magdalena
    Klapaczynski, Jakub
    Piekarska, Anna
    Sitko, Marek
    Laurans, Lukasz
    Parfieniuk-Kowerda, Anna
    Flisiak, Robert
    PHARMACOLOGICAL REPORTS, 2024, 76 (05) : 1114 - 1129
  • [2] Microbial translocation and T cell activation are modified by direct-acting antiviral therapy in HCV-infected patients
    Lattanzi, Barbara
    Baroncelli, Silvia
    De Santis, Adriano
    Galluzzo, Clementina Maria
    Mennini, Gianluca
    Michelini, Zuleika
    Lupo, Marinella
    Corradini, Stefano Ginanni
    Rossi, Massimo
    Palmisano, Lucia
    Merli, Manuela
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (10) : 1146 - 1155
  • [3] Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era
    Stevenson H.L.
    Utay N.S.
    Tropical Diseases, Travel Medicine and Vaccines, 2 (1)
  • [4] Direct-acting antiviral treatment of chronic HCV-infected patients on opioid substitution therapy: Still a concern in clinical practice?
    Christensen, Stefan
    Buggisch, Peter
    Mauss, Stefan
    Boker, Klaus H. W.
    Schott, Eckart
    Klinker, Hartwig
    Zimmermann, Tim
    Weber, Bernd
    Reimer, Jens
    Serfert, Yvonne
    Wedemeyer, Heiner
    ADDICTION, 2018, 113 (05) : 868 - 882
  • [5] Natural History of Decompensated Cirrhosis after Direct-Acting Antivirals (DAA) Treatment of Hepatitis C (HCV)
    Dunn, Winston
    Whitener, Melissa
    Chakraborty, Shweta
    Vittal, Anusha
    Pandya, Prashant K.
    Kallail, K. James
    Bridges, Brian
    Wu, Chuanghong
    Taylor, Ryan
    Olson, Jody C.
    Gilroy, Richard
    Schmitt, Timothy
    Olyaee, Mojtaba S.
    Weinman, Steven A.
    HEPATOLOGY, 2015, 62 : 1093A - 1094A
  • [6] Who Gets Better? Predictors of Clinically Meaningful Improvements in Liver Function among Patients with Decompensated Hepatitis C (HCV) Cirrhosis Receiving Direct-Acting Antiviral (DAA) Therapy
    El Sherif, O.
    Tapper, E.
    Huang, K.
    Osinusi, A.
    Charlton, M.
    Manns, M.
    Afdhal, N.
    Brainard, D.
    Terrault, N.
    Curry, M.
    TRANSPLANTATION, 2017, 101 (05) : 364 - 364
  • [7] IMPACT OF DIRECT ACTING ANTIVIRAL AGENTS (DAA) IN PATIENTS WITH DECOMPENSATED HEPATITIS C VIRUS (HCV) CIRRHOSIS
    Jakhete, Neha
    Shay, Jessica
    Katzianer, Jennifer
    Bowring, Mary
    Gurakar, Ahmet
    Durand, Christine
    Shetty, Kirti
    GASTROENTEROLOGY, 2018, 154 (06) : S1196 - S1196
  • [8] RISK OF HEPATOCELLULAR CARCINOMA IN HCV-RELATED CIRRHOSIS TREATED WITH DIRECT-ACTING ANTIVIRAL (DAA) THERAPY
    Kilany, Shimaa
    Gomaa, Asmaa Ibrahim
    Sabry, Alyaa
    Moaz, Inas
    Ezzat, Sameera
    Badra, Gamal Ahmed
    Waked, Imam
    HEPATOLOGY, 2019, 70 : 321A - 322A
  • [9] Mortality during direct-acting antiviral therapy in HCV/HIV patients with cirrhosis
    Vivancos-Gallego, Maria J.
    Moreno, Ana
    Perez Elias, Maria J.
    Quereda, Carmen
    Luis Casado, Jose
    Gomez Ayerbe, Cristina
    Sanchez-Conde, Matilde
    Del Campo, Santos
    Moreno, Santiago
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
  • [10] Direct-acting antiviral interactions with opioids, alcohol or illicit drugs of abuse in HCV-infected patients
    Lorenzini, Kuntheavy Ing
    Girardin, Francois
    LIVER INTERNATIONAL, 2020, 40 (01) : 32 - 44
12345